AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ruhoglim M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Euphony Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Ruhoglim M 2mg/500mg Tablet SR

Metformin/Rosiglitazone 2mg/500mg extended-release tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are necessary to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before initiating treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Ruhoglim M 2mg/500mg Tablet SR

No text was provided to rewrite.

Uses of Ruhoglim M 2mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Ruhoglim M 2mg/500mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Ruhoglim M 2mg/500mg Sustained-Release tablets with food.

Common Side effects of Ruhoglim M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ruhoglim M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Ruhoglim M 2mg/500mg Extended-Release Tablets with food.

How Ruhoglim M 2mg/500mg Tablet SR works:

Ruhoglim M 2mg/500mg sustained-release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ruhoglim M 2mg/500mg SR tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ruhoglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Ruhoglim M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Ruhoglim M 2mg/500mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Ruhoglim M 2mg/500mg Tablet SR. Physician consultation is recommended. Close monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Exercise caution when administering Ruhoglim M 2mg/500mg Tablet SR to individuals with hepatic impairment. Dosage modification of Ruhoglim M 2mg/500mg Tablet SR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, Ruhoglim M 2mg/500mg Tablet SR should typically commence at a reduced dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Ruhoglim M 2mg/500mg Tablet SR :

Should you forget a dose of Ruhoglim M 2mg/500mg SR Tablet, administer it immediately if you remember. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Ruhoglim M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ruhoglim M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Ruhoglim M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Ruhoglim M 2mg/500mg Tablet SR and seek immediate medical attention.
Ruhoglim M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Ruhoglim M 2mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Ruhoglim M 2mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Ruhoglim M 2mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Ruhoglim M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can worsen the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Ruhoglim M 2mg/500mg Tabl...
57
MRP 70
18% off